Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Pope

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Neuropsychiatry and Clinical Neurosciences|January 3, 2006
Review of pseudobulbar affect including a novel and potential therapyRandolph Schiffer, Laura E Pope
Clinical Drug Investigation|January 31, 2012
Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteersKerri A Schoedel, Laura E Pope, Edward M Sellers
Pain Medicine (Malden, Mass.)|February 9, 2012
Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter studyAziz I Shaibani, Laura E Pope, Ronald Thisted, et al.
Clinical Drug Investigation|June 21, 2012
A study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteersLaura E Pope, Kerri A Schoedel, Cynthia Bartlett, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
Measuring pseudobulbar affect in ALSRichard A Smith, James E Berg, Laura E Pope, et al.
Pharmacology & Therapeutics|May 4, 2016
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical useCharles P Taylor, Stephen F Traynelis, Joao Siffert, et al.
Regulatory Toxicology and Pharmacology : RTP|October 18, 2002
The toxicity of behenyl alcohol. II. Reproduction studies in rats and rabbitsGuadalupe Iglesias, Jason J Hlywka, James E Berg, et al.
Regulatory Toxicology and Pharmacology : RTP|October 18, 2002
The toxicity of behenyl alcohol. I. Genotoxicity and subchronic toxicity in rats and dogsGuadalupe Iglesias, Jason J Hlywka, James E Berg, et al.
Journal of Clinical Pharmacology|September 3, 2004
Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizersLaura E Pope, M H Khalil, James E Berg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patientsRichard A Smith, James E Berg, Laura E Pope, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Neuropsychiatry and Clinical Neurosciences|January 3, 2006
Review of pseudobulbar affect including a novel and potential therapyRandolph Schiffer, Laura E Pope
Clinical Drug Investigation|January 31, 2012
Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteersKerri A Schoedel, Laura E Pope, Edward M Sellers
Pain Medicine (Malden, Mass.)|February 9, 2012
Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter studyAziz I Shaibani, Laura E Pope, Ronald Thisted, et al.
Clinical Drug Investigation|June 21, 2012
A study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteersLaura E Pope, Kerri A Schoedel, Cynthia Bartlett, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
Measuring pseudobulbar affect in ALSRichard A Smith, James E Berg, Laura E Pope, et al.
Pharmacology & Therapeutics|May 4, 2016
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical useCharles P Taylor, Stephen F Traynelis, Joao Siffert, et al.
Regulatory Toxicology and Pharmacology : RTP|October 18, 2002
The toxicity of behenyl alcohol. II. Reproduction studies in rats and rabbitsGuadalupe Iglesias, Jason J Hlywka, James E Berg, et al.
Regulatory Toxicology and Pharmacology : RTP|October 18, 2002
The toxicity of behenyl alcohol. I. Genotoxicity and subchronic toxicity in rats and dogsGuadalupe Iglesias, Jason J Hlywka, James E Berg, et al.
Journal of Clinical Pharmacology|September 3, 2004
Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizersLaura E Pope, M H Khalil, James E Berg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patientsRichard A Smith, James E Berg, Laura E Pope, et al.
Pageof 2